F. Ortega

Value of FDG-PET in the Therapeutic Management of Recurrent Ovarian Cancer. Experience in 31 Patients.

G. Ossola, C. Trampal, R. Pérez-Carrión, 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

European health telematics networks for positron emission tomography

D. Visvikis, C. Rest, G. Kontaxakis, 2006 .

Evaluation of efficacy and clinical impact of positron emission tomography with 18 F fluoro-deoxyglucose ( FDG ) in patients with suspicion of recurrent laryngeal carcinoma

F. Ortega, I. B. Dorado, R. V. Albertino, 2006 .

Cerebral Metabolism and Personality in Patients with Epilepsy of the Temporal Lobe

M. A. Pozo, R. Sola, A. Maldonado, 2006 .

[S100 protein as tumoral marker in melanoma patients. Comparative study with sentinel node biopsy and whole body FDG-PET].

C. Vázquez, B. Ortiz, J. Maíquez, 2003, Revista espanola de medicina nuclear.

Integrated telemedicine applications and services for oncological positron emission tomography.

George Kontaxakis, Leyun Pan, Georgios Sakas, 2006, Oncology reports.

[Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].

I. Mateo, R. Quirce, J. L. Vázquez-Higuera, 2011 .

[Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].

R. Quirce, J. L. Vázquez-Higuera, I. Banzo, 2011, Revista espanola de medicina nuclear.